(Q46346144)

English

HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently

scientific article published on 8 September 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

Soumya Swaminathan

6

object named as

Soumya Swaminathan

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

author name string

Venkatesh Prasanna Kashi

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

Rajesh Abraham Jacob

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

Siddhartha Paul

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

Kaustuv Nayak

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

Bhuthiah Satish

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

Kadappa S Satish

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

Udaykumar Ranga

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

language of work or name

0 references

publication date

8 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

27

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

48

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

6739-6747

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

Multifaceted activities of the HIV-1 transactivator of transcription, Tat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

HIV-1 Tat suppresses gp120-specific T cell response in IL-10-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: implication of protein kinase C-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Pertussis toxin (PTX) B subunit and the nontoxic PTX mutant PT9K/129G inhibit Tat-induced TGF-beta production by NK cells and TGF-beta-mediated NK cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

HIV-1 Tat: immunosuppression via TGF-beta1 induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

HIV-1 Tat Inhibits IL-2 Gene Transcription Through Qualitative and Quantitative Alterations of the Cooperative Rel/AP1 Complex Bound to the CD28RE/AP1 Composite Element of the IL-2 Promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Speed of progression to AIDS and degree of antibody response to accessory gene products of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Tat-specific binding IgG and disease progression in HIV type 1-infected Ugandans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

B-cell epitopes in HIV-1 Tat and Rev proteins colocalize with T-cell epitopes and with functional domains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by elispot and intracellular cytokine staining assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocytes response to HIV type 1 in an infected individual

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Human immunodeficiency virus (HIV) Tat-reactive antibodies present in normal HIV-negative sera and depleted in HIV-positive sera. Identification of the epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Circulating natural IgM antibodies and their corresponding human cord blood cell-derived Mabs specifically combat the Tat protein of HIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Comparison of the efficacy of early versus late viral proteins in vaccination against SIV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Identification of unique B/C recombinant strains of HIV-1 in the southern state of Karnataka, India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Antibody avidity determination by ELISA using thiocyanate elution.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Recognition of envelope and tat protein synthetic peptide analogs by HIV positive sera or plasma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Epitopes for natural antibodies of human immunodeficiency virus (HIV)-negative (normal) and HIV-positive sera are coincident with two key functional sequences of HIV Tat protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Recombinant human Fab antibody fragments to HIV-1 Rev and Tat regulatory proteins: direct selection from a combinatorial phage display library

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

One step forward, two steps back--will there ever be an AIDS vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.078

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.08.078

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

release_wwgjbmicr5dwzmfmzugbnjijny

1 reference

https://api.fatcat.wiki/v0/release/wwgjbmicr5dwzmfmzugbnjijny

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/19744585

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46346144&oldid=2106499595"